EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience

Shireen A. Pais, Mohammad Al-Haddad, Mehdi Mohamadnejad, Julia K. Leblanc, Stuart Sherman, Lee McHenry, John DeWitt

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Background: Pancreatic neuroendocrine tumors (PNTs) are rare tumors with malignant potential. EUS and EUS-guided FNA (EUS-FNA) have been shown to be superior to other imaging methods in the preoperative localization and diagnosis of PNTs. Objectives: To evaluate the clinical presentation, EUS morphology, and sensitivity of EUS-FNA cytology in a large consecutive cohort with histologically and/or cytologically confirmed PNTs. Design: Retrospective study of all consecutive patients from July 1995 to November 2006 who underwent EUS for a known or suspected PNT and had a subsequently histologically confirmed PNT. Setting: Tertiary referral center. Patients: Ninety-two patients with suspected PNT. Interventions: EUS evaluation with or without EUS-FNA of PNTs. Main Outcome Measurements: Clinical and EUS features of PNTs and sensitivity of EUS-FNA for the diagnosis of PNTs. Results: Ninety-two patients underwent EUS; 76 patients had confirmed histopathology, of whom 69 (91%) were symptomatic. Patients with functional PNTs presented with diarrhea, peptic ulcer disease, and hypoglycemia. Tumor locations and echogenic features were similar except that nonfunctional PNTs tended to be larger and have cystic features. Patients with malignant PNTs were older (P = .03), presented with abdominal pain, and had larger tumors (P = .0006) with irregular margins. Eighty-nine percent of patients underwent EUS-FNA. Sensitivity of EUS-FNA for the diagnosis of a PNT was 87%. Sensitivity of EUS-FNA was similar in functional and nonfunctional PNTs. The sensitivity of EUS-FNA was higher for malignant PNTs (P = .008). Limitations: Retrospective single tertiary center. Conclusions: EUS and EUS-FNA are sensitive tools, especially in cases of suspected symptomatic PNTs in which other imaging modalities have failed.

Original languageEnglish (US)
Pages (from-to)1185-1193
Number of pages9
JournalGastrointestinal Endoscopy
Volume71
Issue number7
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Neuroendocrine Tumors
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Neoplasms
Peptic Ulcer
Hypoglycemia
Tertiary Care Centers

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

EUS for pancreatic neuroendocrine tumors : a single-center, 11-year experience. / Pais, Shireen A.; Al-Haddad, Mohammad; Mohamadnejad, Mehdi; Leblanc, Julia K.; Sherman, Stuart; McHenry, Lee; DeWitt, John.

In: Gastrointestinal Endoscopy, Vol. 71, No. 7, 06.2010, p. 1185-1193.

Research output: Contribution to journalArticle

Pais, Shireen A. ; Al-Haddad, Mohammad ; Mohamadnejad, Mehdi ; Leblanc, Julia K. ; Sherman, Stuart ; McHenry, Lee ; DeWitt, John. / EUS for pancreatic neuroendocrine tumors : a single-center, 11-year experience. In: Gastrointestinal Endoscopy. 2010 ; Vol. 71, No. 7. pp. 1185-1193.
@article{1978d9d49ba44cfd94bd29eb6b7a47db,
title = "EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience",
abstract = "Background: Pancreatic neuroendocrine tumors (PNTs) are rare tumors with malignant potential. EUS and EUS-guided FNA (EUS-FNA) have been shown to be superior to other imaging methods in the preoperative localization and diagnosis of PNTs. Objectives: To evaluate the clinical presentation, EUS morphology, and sensitivity of EUS-FNA cytology in a large consecutive cohort with histologically and/or cytologically confirmed PNTs. Design: Retrospective study of all consecutive patients from July 1995 to November 2006 who underwent EUS for a known or suspected PNT and had a subsequently histologically confirmed PNT. Setting: Tertiary referral center. Patients: Ninety-two patients with suspected PNT. Interventions: EUS evaluation with or without EUS-FNA of PNTs. Main Outcome Measurements: Clinical and EUS features of PNTs and sensitivity of EUS-FNA for the diagnosis of PNTs. Results: Ninety-two patients underwent EUS; 76 patients had confirmed histopathology, of whom 69 (91{\%}) were symptomatic. Patients with functional PNTs presented with diarrhea, peptic ulcer disease, and hypoglycemia. Tumor locations and echogenic features were similar except that nonfunctional PNTs tended to be larger and have cystic features. Patients with malignant PNTs were older (P = .03), presented with abdominal pain, and had larger tumors (P = .0006) with irregular margins. Eighty-nine percent of patients underwent EUS-FNA. Sensitivity of EUS-FNA for the diagnosis of a PNT was 87{\%}. Sensitivity of EUS-FNA was similar in functional and nonfunctional PNTs. The sensitivity of EUS-FNA was higher for malignant PNTs (P = .008). Limitations: Retrospective single tertiary center. Conclusions: EUS and EUS-FNA are sensitive tools, especially in cases of suspected symptomatic PNTs in which other imaging modalities have failed.",
author = "Pais, {Shireen A.} and Mohammad Al-Haddad and Mehdi Mohamadnejad and Leblanc, {Julia K.} and Stuart Sherman and Lee McHenry and John DeWitt",
year = "2010",
month = "6",
doi = "10.1016/j.gie.2009.12.006",
language = "English (US)",
volume = "71",
pages = "1185--1193",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "7",

}

TY - JOUR

T1 - EUS for pancreatic neuroendocrine tumors

T2 - a single-center, 11-year experience

AU - Pais, Shireen A.

AU - Al-Haddad, Mohammad

AU - Mohamadnejad, Mehdi

AU - Leblanc, Julia K.

AU - Sherman, Stuart

AU - McHenry, Lee

AU - DeWitt, John

PY - 2010/6

Y1 - 2010/6

N2 - Background: Pancreatic neuroendocrine tumors (PNTs) are rare tumors with malignant potential. EUS and EUS-guided FNA (EUS-FNA) have been shown to be superior to other imaging methods in the preoperative localization and diagnosis of PNTs. Objectives: To evaluate the clinical presentation, EUS morphology, and sensitivity of EUS-FNA cytology in a large consecutive cohort with histologically and/or cytologically confirmed PNTs. Design: Retrospective study of all consecutive patients from July 1995 to November 2006 who underwent EUS for a known or suspected PNT and had a subsequently histologically confirmed PNT. Setting: Tertiary referral center. Patients: Ninety-two patients with suspected PNT. Interventions: EUS evaluation with or without EUS-FNA of PNTs. Main Outcome Measurements: Clinical and EUS features of PNTs and sensitivity of EUS-FNA for the diagnosis of PNTs. Results: Ninety-two patients underwent EUS; 76 patients had confirmed histopathology, of whom 69 (91%) were symptomatic. Patients with functional PNTs presented with diarrhea, peptic ulcer disease, and hypoglycemia. Tumor locations and echogenic features were similar except that nonfunctional PNTs tended to be larger and have cystic features. Patients with malignant PNTs were older (P = .03), presented with abdominal pain, and had larger tumors (P = .0006) with irregular margins. Eighty-nine percent of patients underwent EUS-FNA. Sensitivity of EUS-FNA for the diagnosis of a PNT was 87%. Sensitivity of EUS-FNA was similar in functional and nonfunctional PNTs. The sensitivity of EUS-FNA was higher for malignant PNTs (P = .008). Limitations: Retrospective single tertiary center. Conclusions: EUS and EUS-FNA are sensitive tools, especially in cases of suspected symptomatic PNTs in which other imaging modalities have failed.

AB - Background: Pancreatic neuroendocrine tumors (PNTs) are rare tumors with malignant potential. EUS and EUS-guided FNA (EUS-FNA) have been shown to be superior to other imaging methods in the preoperative localization and diagnosis of PNTs. Objectives: To evaluate the clinical presentation, EUS morphology, and sensitivity of EUS-FNA cytology in a large consecutive cohort with histologically and/or cytologically confirmed PNTs. Design: Retrospective study of all consecutive patients from July 1995 to November 2006 who underwent EUS for a known or suspected PNT and had a subsequently histologically confirmed PNT. Setting: Tertiary referral center. Patients: Ninety-two patients with suspected PNT. Interventions: EUS evaluation with or without EUS-FNA of PNTs. Main Outcome Measurements: Clinical and EUS features of PNTs and sensitivity of EUS-FNA for the diagnosis of PNTs. Results: Ninety-two patients underwent EUS; 76 patients had confirmed histopathology, of whom 69 (91%) were symptomatic. Patients with functional PNTs presented with diarrhea, peptic ulcer disease, and hypoglycemia. Tumor locations and echogenic features were similar except that nonfunctional PNTs tended to be larger and have cystic features. Patients with malignant PNTs were older (P = .03), presented with abdominal pain, and had larger tumors (P = .0006) with irregular margins. Eighty-nine percent of patients underwent EUS-FNA. Sensitivity of EUS-FNA for the diagnosis of a PNT was 87%. Sensitivity of EUS-FNA was similar in functional and nonfunctional PNTs. The sensitivity of EUS-FNA was higher for malignant PNTs (P = .008). Limitations: Retrospective single tertiary center. Conclusions: EUS and EUS-FNA are sensitive tools, especially in cases of suspected symptomatic PNTs in which other imaging modalities have failed.

UR - http://www.scopus.com/inward/record.url?scp=77952959612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952959612&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2009.12.006

DO - 10.1016/j.gie.2009.12.006

M3 - Article

C2 - 20304401

AN - SCOPUS:77952959612

VL - 71

SP - 1185

EP - 1193

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 7

ER -